CD8A and neoplasm: The cell line fails to express E2 and CD8+ T cells to this antigen and thus cannot contribute to the eradication of tumor cells, indicating that the enhanced vaccine immunogenicity and efficacy upon inclusion of E2 reflected an indirect effect on other mechanisms that promote immune activation.